Absence of renal remission portends poor long-term kidney outcome in lupus nephritis

Lupus Sci Med. 2021 Aug;8(1):e000533. doi: 10.1136/lupus-2021-000533.

Abstract

Background: The very long-term consequences of absence of remission in lupus nephritis (LN) remain understudied.

Methods: In this retrospective analysis, we studied a selected cohort of 128 patients with biopsy-proven class III, IV or V incident LN followed for a median period of 134 months (minimum 25). Remission was defined as a urine protein to creatinine (uP:C) ratio <0.5 g/g and a serum creatinine value <120% of baseline. Renal relapse was defined as the reappearance of a uP:C >1 g/g, leading to a repeat kidney biopsy and treatment change. Poor long-term renal outcome was defined as the presence of chronic kidney disease (CKD).

Results: Twenty per cent of patients never achieved renal remission. Their baseline characteristics did not differ from those who did. Absence of renal remission was associated with a threefold higher risk of CKD (48% vs 16%) and a 10-fold higher risk of end-stage renal disease (20% vs 2%). Patients achieving early remission had significantly higher estimated glomerular filtration rate (eGFR) at last follow-up compared with late remitters. Accordingly, patients with CKD at last follow-up had statistically longer time to remission. Among patients who achieved remission, 32% relapsed, with a negative impact on renal outcome, that is, lower eGFR values and higher proportion of CKD (33% vs 8%).

Conclusion: Early remission should be achieved to better preserve long-term renal function.

Keywords: health care; lupus erythematosus; lupus nephritis; outcome assessment; systemic.

MeSH terms

  • Creatinine
  • Glomerular Filtration Rate
  • Humans
  • Kidney / physiology
  • Lupus Nephritis* / complications
  • Retrospective Studies

Substances

  • Creatinine